Unlock Deeper Insights into IBD Drug Discovery with Ace Therapeutics

Are you seeking innovative and validated solutions for inflammatory bowel disease (IBD) research and drug development? Download our latest brochure to explore how Ace Therapeutics, a leading preclinical CRO, empowers your IBD programs with advanced platforms and tailored models. This brochure provides a comprehensive overview of Ace Therapeutics' cutting-edge technologies and one-stop preclinical research services in the field of IBD.

Our Capabilities

• Specialized focus on IBD: Comprehensive services targeting ulcerative colitis, Crohn's disease, and intestinal complications using clinically relevant models.
• Mechanism-based studies: In-depth analyses of immunopathogenesis, gut microbiota, and intestinal barrier dysfunction to support early-stage drug development.
• Quantitative efficacy readouts: Disease activity index (DAI), colon histology, cytokine profiling, intestinal permeability, and more.
• Tailored study designs: Customized protocols based on your compound's mechanism, including target identification, PK/PD studies.

Advanced Technology Platform

• Imaging platform
• Laboratory animal pathology platform
• Gut Microbiota analysis platform
• Molecular biology analysis platform

You might be interested in...